Table 2. Distribution of age, sex and histology by EBV status in Dutch cHL patients.
all patients | EBV+ | EBV- | EBV+ vs. EBV- | ||||
n = 515 | n = 181 | n = 334 | p-value | ||||
n | % | n | % | n | % | ||
sex | |||||||
male | 298 | 58 | 118 | 65 | 180 | 54 | 0.013* |
female | 217 | 42 | 63 | 35 | 154 | 46 | |
histological subtype | |||||||
NS | 413 | 83 | 114 | 66 | 299 | 92 | <0.001† |
MC | 63 | 13 | 48 | 28 | 15 | 4 | |
LR | 12 | 2 | 3 | 2 | 9 | 3 | |
LD | 9 | 2 | 7 | 4 | 2 | 1 | |
NOS | 18 | 9 | 9 | ||||
median age (range) | 37 (8–94) | 43 (8–94) | 34 (9–90) | <0.001‡ |
*Chi square test, † Fisher's exact test, NOS cases were excluded, ‡ Mann Whitney U test, NS indicates nodular sclerosis; MC, mixed cellularity; LR, lymphocyte rich; LD lymphocyte depletion; NOS, not otherwise specified.